Russia’s first bioprinter went on display Tuesday at an international bioprinting and biofabrication conference at the Skolkovo Hypercube.
For the second year running the Skolkovo Innovation Center is holding one of the world's top events in biotechnology.
This year, a very topical theme in the development of regenerative medicine has been chosen - the technology of bioprinting.
“The leading IT companies have introduced bioprinting into the top 200 technologies of the future in medicine and IT,” said Lyudmila Ogorodnikova, Russia’s deputy education and science minister.
She singled out Vladimir Mironov, the creator of Russia’s first bioprinter, for his role in advancing domestic science.
“I would like to thank the Russian scientist who made the first bioprinter in Russia and plans to receive intellectual property rights to it. It’s very important that intellectual property is assigned to Russia in such a breakthrough field,” Ogordnikova added.
A bioprinter is a machine that fabricates human cells, a technology that could revolutionize modern medicine by providing everything from skin grafts to replacement organs.
Mironov’s Moscow-based firm 3D Bioprinting Solutions, a resident of Skolkovo’s Biomed cluster, put its Fabion bioprinter on display at the Hypercube.
Mironov’s company predicts that complete organ replacements are still more than a decade away, and that providing replacement skin tissue is a more immediate application of the technology - though even that is at least four years off.
In 2013, a conference on regenerative medicine was held at the Hypercube, presenting to Russia leading experts in the field and generating huge interest and audience participation.
The International Conference on Bioprinting and Biofabrication covers the following topics: The technologies of biofabrication, bioprinting, and organ bioprinting; cell technologies, cellular engineering; engineering and technical solutions to elements of the bioprinting technological platform; material engineering: bio-ink, bio-paper; legislative framework, including registering and certification of cellular and tissue constructors Implementation in practical healthcare.
The conference agenda can be viewed here.
.